Nov 23 (Reuters) - Ceapro Inc :
* Ceapro Inc- qtrly earnings per share $0.01
* Will "commence patient recruitment for pilot clinical study to develop beta glucan as a cholesterol reducer in Q1 2017"
* Ceapro Inc reports third quarter 2016 financial and operational results
* Q3 sales C$3.018 million Source text for Eikon: Further company coverage: